• VERTEX PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: VRTX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.263 Buy 19
    30 Days Ago 2.150 Buy 20
    60 Days Ago 2.200 Buy 20
    90 Days Ago 2.316 Buy 19
    120 Days Ago 2.350 Buy 20

  • Analyst Ratings: VRTX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Oppenheimer Outperform Perform 09/03/2008 —
    Leerink Swann — Outperform 06/09/2008 40.00
    Susquehanna Financial — Positive 06/06/2008 37.00
    Leerink Swann — Outperform 06/05/2008 35.00
    Cowen & Co Neutral Outperform 06/05/2008 —
    JMP Securities Mkt Outperform Mkt Perform 06/04/2008 —
    Pacific Growth Equities — Buy 05/21/2008 —
    Canaccord Adams — Hold 04/28/2008 28.00
    Leerink Swann — Outperform 04/25/2008 —
    JMP Securities — Mkt Outperform 04/10/2008 30.00
    Robert W. Baird Neutral Outperform 04/01/2008 33.00
    Wachovia Underperform Mkt Perform 04/01/2008 —
    Susquehanna Financial Neutral Positive 03/31/2008 —
    Lazard Capital Sell Hold 03/12/2008 —
    Merriman Curhan Ford — Neutral 03/11/2008 —
    Lazard Capital — Sell 02/04/2008 13.00
    JMP Securities — Mkt Outperform 01/29/2008 —
    UBS — Buy 01/24/2008 37.00
    Citigroup Buy Hold 01/24/2008 —
    Banc of America Sec Neutral Buy 01/16/2008 34.00
    Robert W. Baird — Neutral 01/15/2008 25.00
    Wachovia Mkt Perform Underperform 01/03/2008 —
    Lazard Capital — Sell 12/13/2007 16.00
    Rodman & Renshaw Mkt Outperform Mkt Perform 11/05/2007 —
    Cowen & Co Outperform Neutral 10/19/2007 —
    BMO Capital Markets — Outperform 09/28/2007 44.00
    Stifel Nicolaus — Buy 09/04/2007 45.00
    Deutsche Securities — Buy 08/20/2007 40.00
    Cowen & Co — Outperform 08/08/2007 —
    Stifel Nicolaus — Buy 07/25/2007 35.00
    Next